BACKGROUND: The role of routine supplemental oxygen for patients with uncomplicated acute myocardial infarction (AMI) has recently been questioned. There is conflicting data on the possible effects of hyperoxia on ischemic myocardium. The few clinical trials examining the role of oxygen in AMI were performed prior to the modern approach of emergent reperfusion and advanced medical management. METHODS:Air Verses Oxygen In myocarDial infarction study (AVOID Study) is a prospective, multi-centre, randomized, controlled trial conducted by Ambulance Victoria and participating metropolitan Melbourne hospitals with primary percutaneous coronary intervention capabilities. The purpose of the study is to determine whether withholding routine supplemental oxygen therapy in patients with acute ST-elevation myocardial infarction but without hypoxia prior to reperfusion decreases myocardial infarct size. AVOID will enroll 490 patients, >18 years of age with acute ST-elevation myocardial infarction of less than 12 hours duration. CONCLUSIONS: There is an urgent need for clinical trials examining the role of oxygen in AMI. AVOID will seek to clarify this important issue. Results from this study may have widespread implications on the treatment of AMI and the use of oxygen in both the pre-hospital and hospital settings. Copyright Â
RCT Entities:
BACKGROUND: The role of routine supplemental oxygen for patients with uncomplicated acute myocardial infarction (AMI) has recently been questioned. There is conflicting data on the possible effects of hyperoxia on ischemic myocardium. The few clinical trials examining the role of oxygen in AMI were performed prior to the modern approach of emergent reperfusion and advanced medical management. METHODS: Air Verses Oxygen In myocarDial infarction study (AVOID Study) is a prospective, multi-centre, randomized, controlled trial conducted by Ambulance Victoria and participating metropolitan Melbourne hospitals with primary percutaneous coronary intervention capabilities. The purpose of the study is to determine whether withholding routine supplemental oxygen therapy in patients with acute ST-elevation myocardial infarction but without hypoxia prior to reperfusion decreases myocardial infarct size. AVOID will enroll 490 patients, >18 years of age with acute ST-elevation myocardial infarction of less than 12 hours duration. CONCLUSIONS: There is an urgent need for clinical trials examining the role of oxygen in AMI. AVOID will seek to clarify this important issue. Results from this study may have widespread implications on the treatment of AMI and the use of oxygen in both the pre-hospital and hospital settings. Copyright Â
Authors: E R Hedegaard; B D Nielsen; A Kun; A D Hughes; C Krøigaard; S Mogensen; V V Matchkov; O Fröbert; U Simonsen Journal: Br J Pharmacol Date: 2014-01 Impact factor: 8.739
Authors: Hendrik J F Helmerhorst; Marcus J Schultz; Peter H J van der Voort; Evert de Jonge; David J van Westerloo Journal: Crit Care Date: 2015-08-17 Impact factor: 9.097
Authors: Himawan Fernando; Ziad Nehme; Karlheinz Peter; Stephen Bernard; Michael Stephenson; Janet Bray; Peter Cameron; Andris Ellims; Andrew Taylor; David M Kaye; Karen Smith; Dion Stub Journal: Open Heart Date: 2020-07
Authors: B Ronan O'Driscoll; Nawar Diar Bakerly; Ann-Louise Caress; June Roberts; Miriam Gaston; Mark Newton; Janelle Yorke Journal: BMJ Open Respir Res Date: 2016-05-05
Authors: Maciej Siński; Jacek Lewandowski; Anna Dobosiewicz; Jacek Przybylski; Piotr Abramczyk; Zbigniew Gaciong Journal: Arch Med Sci Date: 2016-08-24 Impact factor: 3.318
Authors: Stephanie Armstrong; Adele Langlois; Despina Laparidou; Mark Dixon; Jason P Appleton; Philip M Bath; Helen Snooks; A Niroshan Siriwardena Journal: BMC Med Res Methodol Date: 2017-09-16 Impact factor: 4.615